Equitec Proprietary Markets’s Revelation Biosciences Warrant REVBW Stock Holding History

Equitec Proprietary Markets’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,000	Closed	-$530	–	88
2024 Q1	$530	Hold	20,000	–	–	﹤0.01%	77
2023 Q4	$212	Hold	20,000	–	–	﹤0.01%	97
2023 Q3	$338	Hold	20,000	–	–	﹤0.01%	116
2023 Q2	$356	Hold	20,000	–	–	﹤0.01%	102
2023 Q1	$324	Hold	20,000	–	–	﹤0.01%	143
2022 Q4	$262	Hold	20,000	–	–	﹤0.01%	189
2022 Q3	$1K	Hold	20,000	–	–	﹤0.01%	226
2022 Q2	$2K	Hold	20,000	–	–	﹤0.01%	222
2022 Q1	$3K	Sell	20,000 -50,000	-71%	-$12.8K	﹤0.01%	204
2021 Q4	$48K	Buy	70,000 +30,000	+75%	+$18.4K	0.01%	215
2021 Q3	$25K	Buy	+40,000	New	+$24.2K	﹤0.01%	169

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Equitec Proprietary Markets's REVBW Position: Q2 2024 in Review

Equitec Proprietary Markets sold out of Revelation Biosciences Warrant (REVBW) in Q2 2024, closing a stake of 20,000 shares — an estimated $530 sold.

Equitec Proprietary Markets first reported a position in REVBW in Q3 2021 and held it in 11 quarters. The position peaked at $48K in Q4 2021. 14 funds tracked by Wall St. Rank hold REVBW as of Q2 2024.

Equitec Proprietary Markets reported no remaining Revelation Biosciences Warrant position as of Q2 2024 after selling out during the quarter.
Equitec Proprietary Markets sold 20,000 Revelation Biosciences Warrant shares in Q2 2024, an estimated $530.
Equitec Proprietary Markets first reported a position in Revelation Biosciences Warrant in Q3 2021 and held it in 11 quarters.
Equitec Proprietary Markets's Revelation Biosciences Warrant position peaked at $48K in Q4 2021.
14 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2024.

Based on Equitec Proprietary Markets's 13F filing for Q2 2024, filed 12 Jul 2024.